Page last updated: 2024-11-12

n-(6-(biotinamido)hexyl)-3'-(2'-pyridyldithio)propionamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(6-(biotinamido)hexyl)-3'-(2'-pyridyldithio)propionamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15949894
SCHEMBL ID1305633
MeSH IDM0486444

Synonyms (25)

Synonym
SCHEMBL1305633
biotin-hpdp
biotin hpdp
129179-83-5
BP-22637
B5749
n-(6-(biotinamido)hexyl)-3'-(2'-pyridyldithio)propionamide
J-005657
5-[(3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]-n-(6-{3-[(pyridin-2-yl)disulfanyl]propanamido}hexyl)pentanamide
DTXSID90580280
n-[6-(biotinamido)hexyl]-3-(2-pyridyldithio)propionamide
5-((3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl)-n-(6-(3-(pyridin-2-yldisulfanyl)propanamido)hexyl)pentanamide ,
mfcd00078541
n-[6-(biotinamido)hexyl]-3a?(2a?pyridyldithio)-propionamide
5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[6-[3-(pyridin-2-yldisulfanyl)propanoylamino]hexyl]pentanamide
D89163
biotin hpdp is known as a sulfhydryl-reactive biotinylation reagent.
n-[6-(biotinamido)hexyl]-3'-(2'-pyridyldithio)-propionamide
EX-A5398
pyridyldisulfide-biotin
pyridyldithiol-biotin
biotinhpdp
CS-0133567
HY-136769
AKOS040744478
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.84 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]